Mark F. McCarty. (2015). Flavones and Flavonols may have Clinical Potential as CK2 Inhibitors in Cancer Therapy. Cancer Studies and Molecular Medicine , 2(1), 39–51. https://doi.org/10.17140/CSMMOJ-2-105